This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Waterloo directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $852,976
Smart Screening for Hepatitis C: A Machine Learning Approach to Find Undiagnosed Infection in Canada
CIHR · 2026 · Principal investigator
- $100,000
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
CIHR · 2023 · Co-investigator
- $150,000
Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion
CIHR · 2022 · Co-investigator
Smart Screening for Hepatitis C: A Machine Learning Approach to Find Undiagnosed Infection in Canada
Principal investigators: Wong, William Wai Lun; Feng, Zeny Z; Mendlowitz, Andrew B
Keywords: Health Administrative Data; Hepatitis C; Machine Learning; Undiagnosed Population
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
Principal investigators: Wong, William Wai Lun
Keywords: Hepatitis B; Mathematical Modelling; Prevalence
Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion
Principal investigators: Wong, William Wai Lun; Popovic, Nashira
Keywords: Hepatitis C; Mathematical Modelling; Prevalence
Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
Principal investigators: Wong, William Wai Lun; Chan, Kelvin K; Prica, Anca
Keywords: Chimeric Antigen Receptor T-Cells; Cost-Effectiveness Analysis; Health Utility; Out-Of-Pocket Costs; Quality Of Life; Time Costs
Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data
Principal investigators: Wong, William Wai Lun
Keywords: Hepatitis B; Mathematical Modelling; Prevalence
Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work
Principal investigators: Wong, William Wai Lun; Chan, Kelvin K
Keywords: Chimeric Antigen Receptor T-Cells; Cost-Effectiveness Analysis; Health Utility; Out-Of-Pocket Costs; Quality Of Life; Time Costs
Towards eliminating viral hepatitis - Addressing hepatitis B using a multidisciplinary approach
Principal investigators: Wong, William Wai Lun; Sander, Beate H
Keywords: Cost-Effectiveness Analysis; Hepatitis B; Infectious Disease Model; Out-Of- Pocket Costs; Policy Model; Preferences; Quality Of Life; Time Costs; Utility
Understanding the treatment benefits of novel antiviral agents for hepatitis C: quality of life, health utility, cost, and return to work
Principal investigators: Wong, William Wai Lun; Krahn, Murray D
Keywords: Cost-Effectiveness; Direct-Acting Antiviral Therapies; Hepatitis C; Out-Of-Pocket Costs; Preferences; Quality Of Life; Time Costs; Utility
Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection
Principal investigators: Wong, William Wai Lun; Krahn, Murray D
Keywords: Cost-Effectivenss; Direct-Acting Antiviral Therapies; Hepatitis C; Out-Of-Pocket Costs; Preferences; Quality Of Life; Time Costs; Utility
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.